Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units
Launched by ABDERRAHMANE MAMI HOSPITAL · Apr 27, 2024
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into the presence and effects of highly resistant bacteria that can cause serious infections in patients in Intensive Care Units (ICUs) in Tunisia. Specifically, it focuses on bacteria that are resistant to common antibiotics, making them harder to treat. The researchers want to understand how these infections happen, what factors may increase the risk of getting them, and how they affect patient care.
If you're an adult patient in the ICU during the study period, you may be eligible to participate. There are no specific exclusions, so most ICU patients can join the study. If you take part, you can expect to help researchers gather important information that could improve treatment for infections caused by these tough bacteria. This study is currently recruiting participants, and your involvement could lead to better outcomes for patients facing similar health challenges in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult ICU patients admitted during the study period
- Exclusion Criteria:
- • none
About Abderrahmane Mami Hospital
Abderrahmane Mami Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Located in Tunisia, the hospital is equipped with state-of-the-art facilities and a multidisciplinary team of healthcare professionals committed to conducting ethically sound and scientifically rigorous studies. The institution focuses on a wide range of therapeutic areas, aiming to contribute valuable insights to the global medical community while ensuring the highest standards of patient care and safety. Through its clinical trial initiatives, Abderrahmane Mami Hospital strives to enhance treatment options and foster advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ariana, Tunis, Tunisia
Patients applied
Trial Officials
Amira JAMOUSSI, Professor
Principal Investigator
Abderrahmen Mami Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported